Gambler: totally agree re visuals, and also agree that the story of "4" likely has most probative value re Leronlimab's efficacy, but essential that any chart be simple and easy to grasp in seconds. Designing such a visual is often easier said than done. Going with Lawman's first 3 bullet points would be easier and safer, imo. Hope Nader reads the board!